Shares of SIGA Technologies (SIGA) were hammered -43% during the afternoon session today, after...

|By:, SA News Editor

Shares of SIGA Technologies (SIGA) were hammered -43% during the afternoon session today, after a Delaware court ruled in favor of PharmAthene (PIP) in a dispute involving SIGA's smallpox drug ST-246. Under the ruling, SIGA can keep the first $40M in net profit from sales of the drug, after which it must then hand over 50% of the net profits to PharmAthene for the next ten years.